Fox Run Management L.L.C. Acquires Shares of 14,544 Stevanato Group S.p.A. (NYSE:STVN)

Fox Run Management L.L.C. purchased a new stake in Stevanato Group S.p.A. (NYSE:STVN) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 14,544 shares of the company’s stock, valued at approximately $317,000.

Other institutional investors have also made changes to their positions in the company. M&T Bank Corp acquired a new position in shares of Stevanato Group during the 4th quarter worth about $572,000. Mutual of America Capital Management LLC bought a new position in Stevanato Group during the fourth quarter worth about $13,848,000. Wellington Management Group LLP raised its position in shares of Stevanato Group by 4.5% during the third quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after purchasing an additional 115,050 shares during the period. Jennison Associates LLC acquired a new position in shares of Stevanato Group in the 4th quarter valued at approximately $20,239,000. Finally, Glenmede Trust Co. NA increased its stake in Stevanato Group by 12.7% during the 3rd quarter. Glenmede Trust Co. NA now owns 35,941 shares of the company’s stock worth $719,000 after purchasing an additional 4,050 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on STVN shares. Morgan Stanley reissued an “equal weight” rating and set a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Bank of America lifted their price target on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. William Blair reaffirmed an “outperform” rating on shares of Stevanato Group in a research report on Friday, March 7th. Wolfe Research initiated coverage on Stevanato Group in a research report on Friday, December 13th. They issued an “outperform” rating and a $28.00 target price on the stock. Finally, UBS Group decreased their price target on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research note on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of €25.70 ($27.63).

Stevanato Group Trading Down 0.5 %

Shares of Stevanato Group stock opened at €21.00 ($22.58) on Thursday. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The business has a fifty day simple moving average of €21.01 and a two-hundred day simple moving average of €20.59. Stevanato Group S.p.A. has a 1 year low of €16.56 ($17.81) and a 1 year high of €33.49 ($36.01). The company has a market capitalization of $6.36 billion, a price-to-earnings ratio of 44.68, a P/E/G ratio of 7.18 and a beta of 0.60.

Stevanato Group (NYSE:STVN) last posted its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €352.68 million during the quarter, compared to analysts’ expectations of €346.26 million. Research analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.